Research

Studies shows
taxifolin benefits

Choose the section to Explore the main Researches

Heart diseases Circulation disorders

Studies shows taxifolin benefits against ischemic heart disease and hypertension
Journal of Biomedical Science Volume 13, pages 127–141(2006).
Taxifolin ameliorates cerebral ischemia-reperfusion injury in rats through its anti-oxidative effect and modulation of NF-kappa B activation
GeroScienceOfficial Journal of the American Agin Association (AGE)
Effects of taxifolin on the activity of angiotensin-converting enzyme and reactive oxygen and nitrogen species in the aorta of aging rats and rats treated with the nitric oxide synthase inhibitor and dexamethasone
PeerJ Life and EnvironmentBiochemistry, Biophysics and Molecular Biology section
Taxifolin protects rat against myocardial ischemia/reperfusion injury by modulating the mitochondrial apoptosis pathway
Toxicology and Applied Pharmacology
Taxifolin protects against cardiac hypertrophy and fibrosis during biomechanical stress of pressure overload
Food and Function (Journal)
Cardioprotective effects of dihydroquercetin against ischemia reperfusion injury by inhibiting oxidative stress and endoplasmic reticulum stress-induced apoptosis viathe PI3K/Akt pathway

Inflammation Infections

Studies show taxifolin reduces inflamation and inhibits viruses activity
Departement of
Pharmaceutical Sciences
University of Basel Inhibitors for Novel Coronavirus Protease Read more
European Review Medical
Pharmacological Sciences
Prospects for the use of regulators of oxidative stress in the comprehensive treatment of the novel Coronavirus Disease 2019 (COVID-19) and its complications
Japanese Journal of
Pharmacology
ANTI-INFLAMMATORY ACTIVITY OF TAXIFOLIN
Archives of Virology 
Virus-inhibiting activity of dihydroquercetin, a flavonoid from Larix sibirica, against coxsackievirus B4 in a model of viral pancreatitis
Phytochemistry
An insight into the health-promoting effects of taxifolin (dihydroquercetin) Read more

Dementia Alzheimer’s

Studies show taxifolin neuroprotection properties. 
The Journal of Alzheimer's
Association
Taxifolin is a novel therapeutic agent for Alzheimer’s disease and cerebral amyloid angiopathy
Clinical Research Institute National Hospital Organization Kyoto Medical Center, Japan Stanford University School of Medicine, Stanford, CA, USA
Pleiotropic neuroprotective effects of taxifolin in cerebral amyloid angiopathy
International Journal
of Molecular Sciences
Novel Therapeutic Potentials of Taxifolin for Amyloid-β-associated Neurodegenerative Diseases and Other Diseases: Recent Advances and Future Perspectives